Functional versus functional and anatomical criteria-guided ranibizumab treatment in patients with neovascular age-related macular degeneration – results from the randomized, phase IIIb OCTAVE study

To evaluate the efficacy and safety of two individualized ranibizumab retreatment schemes in neovascular age-related macular degeneration.

Source: BMC Ophthalmology - January 9, 2020 Category: Opthalmology Authors: Giovanni Staurenghi, Justus G. Garweg, Bianca S. Gerendas, Wayne Macfadden, Boris Gekkiev, Philippe Margaron, Cornelia Dunger-Baldauf and Petr Kolar Tags: Research article Source Type: research